Researcher
Paul Cos
- Research Expertise:In vitro and in vivo biofilm assays, Integrated antimicrobial (bacteria, fungi, yeasts and parasites) screening and profiling of pure compounds and extracts, targeting redox homeostasis in mycobacteria
- Keywords:MICROBIOLOGY, BACTERIOLOGY, BIOFILMS, INFLAMMATION, Pharmacy and pharmacology
- Disciplines:Microbiology, Systems biology, Laboratory medicine
- Research techniques:In vitro and in vivo (pre-clinical) models of infectious diseases (bacteria and fungi), evaluation of drugs
- Users of research expertise:Pharmaceutical companies (big pharma, SME, spin-off), news agencies, journalists, government agencies, regulatory (EU) agencies, non-governmental organisations in the field of infectious diseases
Affiliations
- Laboratory for Microbiology, Parasitology and Hygiene (LMPH) (Research group)
Responsible
From1 Oct 2020 → Today - Laboratory for Microbiology, Parasitology and Hygiene (LMPH) (Research group)
Member
From1 Oct 2006 → 30 Sep 2020
Projects
1 - 10 of 59
- SEP BOF 2022 - DelNAM PlusFrom1 Dec 2022 → TodayFunding: BOF - projects
- Prevention of ventilator-associated pneumonia: analysis of the in vitro and in vivo anti-biofilm capacity of cecropin-based coatings on endotracheal tubes.From1 Nov 2022 → TodayFunding: FWO fellowships
- Chemical probes for imaging bacterial proteases in lung infections.From1 Nov 2022 → TodayFunding: BOF - postdoctoral mandates
- Respiratory co-infection models for fundamental and translational biomedical research.From1 Nov 2022 → TodayFunding: BOF - postdoctoral mandates
- Infrastructure for Diverse Applications of Single Cell Sorting and Dispensing using Microfluidics.From1 Jun 2022 → TodayFunding: BOF - scientific equipment program
- Implementation of in vivo models to identify potential candidates for treatment of Dry Eye DiseaseFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - projects
- Persistence in Streptococcus pneumoniae infections: elucidation of the importance of persister cells in chronic and recurrent infectionsFrom1 Nov 2020 → TodayFunding: FWO fellowships
- In vivo evaluation of biofilm-related pneumonia.From1 Oct 2020 → 30 Sep 2021Funding: BOF - projects
- Springboard for excellence in advanced development of antibacterials (SPRINGBOARD).From1 Sep 2020 → TodayFunding: H2020-EU.4. - Spreading excellence and widening participation
- 3D printing of drug loaded medical devices for personalized medicine.From1 May 2020 → 30 Apr 2022Funding: IOF - technology concept exploration
Publications
11 - 20 of 272
- Expanding the squaramide library as mycobacterial ATP synthase inhibitors(2023)
Authors: Jan Chasák, Lauren Oorts, Milan Dak, Veronika Šlachtová, Václav Bazgier, Karel Berka, Linda De Vooght, Natalia Smiejkowska, Laurence Van Moll, Davie Cappoen, et al.
Pages: 1 - 18 - Antibacterial and insecticide activities of the Persea americana Mill seeds(2023)
Authors: Silvia Molina Bertrán, Paul Cos, Idelsy Chil Nuñez
Number of pages: 92 - Risk factors associated with severe RSV infection in infants(2023)
Authors: Kim Stobbelaar, Thomas C. Mangodt, Winke Van der Gucht, Lise Delhaise, Jasmine Andries, Valerie Gille, Cyril Barbezange, Annemieke Smet, Benedicte De Winter, Jozef De Dooy, et al.
Pages: 1 - 11 - Subtractive immunization as a method to develop respiratory syncytial virus (RSV)—specific monoclonal antibodies(2023)
Authors: Lotte Jacobs, Kim Stobbelaar, Annick Heykers, Paul Cos, Peter Delputte
Pages: 1 - 12 - Phytochemical characterization and antifungal potential of leaf extracts of Mosiera bullata(2023)
Authors: Lianny Pérez-Gómez, Aurora T. Pérez-Martínez, Luc Pieters, Daniel Mendez, Yemeys Quirós-Molina, Reinaldo Trujillo, Emmy Tuenter, Paul Cos
Pages: 1 - 10 - Novel design for an additively manufactured nozzle to produce tubular scaffolds via fused filament fabrication(2022)
Authors: Bahaa Shaqour, Żaneta Górecka, Agnieszka Chmielewska, Bartłomiej Wysocki, Marcin Heljak, Maarten Gernaey, Bart Verleije, Koen Beyers, Chris Vervaet, Emilia Choińska, et al.
- Can 3D printing technologies advance the production of drug delivery systems?(2022)
Authors: Bahaa Shaqour, Paul Cos, Koen Beyers
Number of pages: 260 - Novel flavonol-3-O-methylethers from Zanthoxylum pistaciifolium Griseb. (Rutaceae)(2022)
Authors: Yamilé Heredia Díaz, Emmy Tuenter, Jesús Garcia-Díaz, Ania Ochoa Pacheco, Paul Cos, Luc Pieters, Julio César Escalona Arranz
Pages: 4869 - 4878 - Technological, biochemical and microbiological evaluation of dehydrated Pleurotus ostreatus powder for nutraceutical applications(2022)
Authors: Daily Arias-Ramos, Idelsy Chil-Nunez, Humberto J. Morris, Miladis Camacho-Pozo, Yamila Lebeque-Perez, Gabriel Llaurado-Maury, Paul Cos, Chris Vervaet
Pages: 507 - 514 - A niclosamide-releasing hot-melt extruded catheter prevents **Staphylococcus aureus** experimental biomaterial-associated infection(2022)
Authors: Jesus Augusto Vazquez-Rodriguez, Bahaa Shaqour, Clara Guarch-Pérez, Emilia Choińska, Martijn Riool, Bart Verleije, Koen Beyers, Vivian J.A. Costantini, Wojciech Święszkowski, Sebastian A.J. Zaat, et al.
Pages: 1 - 15
Patents
1 - 5 of 5
- Compositions against candida infections (Inventor)
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases. (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- Compositions against candida infections (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
Linked dataset
1 - 1 of 1